Terms: = Breast cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Diagnosis
34 results:
1. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
[TBL] [Abstract] [Full Text] [Related]
2. Combined effects of naringin and doxorubicin on the JAK/STAT signaling pathway reduce the development and spread of breast cancer cells.
Effat H; Abosharaf HA; Radwan AM
Sci Rep; 2024 Feb; 14(1):2824. PubMed ID: 38310190
[TBL] [Abstract] [Full Text] [Related]
3. The obeticholic acid can positively regulate the cancerous behavior of MCF7 breast cancer cell line.
Rahmani R; Eivazi N; Emamgholipour S; Aminian M; Jalilian A; Paknejad M
Mol Biol Rep; 2024 Feb; 51(1):250. PubMed ID: 38302816
[TBL] [Abstract] [Full Text] [Related]
4. Latent pathway-based Bayesian models to identify intervenable factors of racial disparities in breast cancer stage at diagnosis.
Lee I; Luo Y; Carretta H; LeBlanc G; Sinha D; Rust G
Cancer Causes Control; 2024 Feb; 35(2):253-263. PubMed ID: 37702967
[TBL] [Abstract] [Full Text] [Related]
5. lncSNHG3 drives breast cancer progression by epigenetically increasing CSNK2A1 expression level.
Nie Z; Xu M; Zhou L; Pan B; Xu T; He B; Wang S
Aging (Albany NY); 2023 Jun; 15(12):5734-5750. PubMed ID: 37348024
[TBL] [Abstract] [Full Text] [Related]
6. Differential silencing of stat3 isoforms leads to changes in stat3 activation.
Shamir I; Tsarfaty I; Paret G; Nevo-Caspi Y
Oncotarget; 2023 Apr; 14():366-376. PubMed ID: 37097001
[TBL] [Abstract] [Full Text] [Related]
7. Metadherin Regulates Inflammatory breast cancer Invasion and Metastasis.
Ortiz-Soto G; Babilonia-Díaz NS; Lacourt-Ventura MY; Rivera-Rodríguez DM; Quiñones-Rodríguez JI; Colón-Vargas M; Almodóvar-Rivera I; Ferrer-Torres LE; Suárez-Arroyo IJ; Martínez-Montemayor MM
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902125
[TBL] [Abstract] [Full Text] [Related]
8. Downregulation of
Shishavan NS; Sasani ST; Salehi Z; Azhang MR
Microrna; 2022; 11(3):263-270. PubMed ID: 36082867
[TBL] [Abstract] [Full Text] [Related]
9. The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.
Zhang JN; Ding DY; Yang SY; Tao QF; Yang Y; Zhou WP
Pathol Res Pract; 2022 Aug; 236():153989. PubMed ID: 35753134
[TBL] [Abstract] [Full Text] [Related]
10. The potential of B7-H6 as a therapeutic target in cancer immunotherapy.
Mohammadi A; Najafi S; Amini M; Mansoori B; Baghbanzadeh A; Hoheisel JD; Baradaran B
Life Sci; 2022 Sep; 304():120709. PubMed ID: 35697295
[TBL] [Abstract] [Full Text] [Related]
11. Downregulation of long noncoding RNA breast cancer anti-estrogen resistance 4 inhibits cell proliferation, invasion, and migration in esophageal squamous cell carcinoma by regulating the microRNA-181c-5p/LIM and SH3 protein 1 axis.
Ke S; Fang M; Li R; Wang J; Lu J
Bioengineered; 2022 May; 13(5):12998-13010. PubMed ID: 35611706
[TBL] [Abstract] [Full Text] [Related]
12. IL-6 Cytokine Family: A Putative Target for breast cancer Prevention and Treatment.
Felcher CM; Bogni ES; Kordon EC
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163731
[TBL] [Abstract] [Full Text] [Related]
13. Comparative Effectiveness of Digital breast Tomosynthesis and Mammography in Older Women.
Upneja A; Long JB; Aminawung JA; Kyanko KA; Kunst N; Xu X; Busch SH; Gross CP; Richman IB
J Gen Intern Med; 2022 Jun; 37(8):1870-1876. PubMed ID: 34595682
[TBL] [Abstract] [Full Text] [Related]
14. PIWI‑interacting RNA in cancer: Molecular mechanisms and possible clinical implications (Review).
Yuan C; Qin H; Ponnusamy M; Chen Y; Lin Z
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34328192
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma.
Yang Z; Yin L; Zeng Y; Li Y; Chen H; Yin S; Zhang F; Yang W
Virchows Arch; 2021 Nov; 479(5):947-959. PubMed ID: 34148127
[TBL] [Abstract] [Full Text] [Related]
16. Nonmalignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALCL: A Premalignant Step?
Kadin ME; Xu H; Hunsicker LM; Guan Y
Aesthet Surg J; 2022 Jan; 42(2):NP125-NP129. PubMed ID: 33944901
[TBL] [Abstract] [Full Text] [Related]
17. Signaling pathways governing breast cancer stem cells behavior.
Song K; Farzaneh M
Stem Cell Res Ther; 2021 Apr; 12(1):245. PubMed ID: 33863385
[TBL] [Abstract] [Full Text] [Related]
18. CircHIF1A regulated by FUS accelerates triple-negative breast cancer progression by modulating NFIB expression and translocation.
Chen T; Wang X; Li C; Zhang H; Liu Y; Han D; Li Y; Li Z; Luo D; Zhang N; Zheng M; Chen B; Wang L; Zhao W; Yang Q
Oncogene; 2021 Apr; 40(15):2756-2771. PubMed ID: 33714984
[TBL] [Abstract] [Full Text] [Related]
19. A randomised online experimental study to compare responses to brief and extended surveys of health-related quality of life and psychosocial outcomes among women with breast cancer.
Ettridge K; Caruso J; Roder D; Prichard I; Scharling-Gamba K; Wright K; Miller C
Qual Life Res; 2021 Feb; 30(2):407-423. PubMed ID: 32990882
[TBL] [Abstract] [Full Text] [Related]
20. ZIC2 is downregulated and represses tumor growth via the regulation of stat3 in breast cancer.
Liu ZH; Chen ML; Zhang Q; Zhang Y; An X; Luo YL; Liu XM; Liu SX; Liu Q; Yang T; Liu YM; Liu BL; Zhou AJ; Li MZ; Liu YJ; Liu ZX; Zhong Q
Int J Cancer; 2020 Jul; 147(2):505-518. PubMed ID: 32064600
[TBL] [Abstract] [Full Text] [Related]
[Next]
